INTRODUCTION: Hippocampal volume (HV), cortical metabolism, and thickness are decreased in mild cognitive impairment (MCI). Hippocampal metabolism (HM) studies comparing MCI and clinically normal (CN) elderly gave inconsistent results. As hippocampus is a key region in Alzheimer's disease, we hypothesized that HM is specifically decreased in high-amyloid MCI. METHODS: Overall, 250 CN and 45 MCI underwent three-dimensional magnetic resonance imaging, fludeoxyglucose-positron emission tomography, and fluorodeoxyglucose-positron emission tomography (PET), and Pittsburgh Compound B (PiB) PET. We investigated the interaction between clinical and amyloid status on HM, HV, cortical metabolism, and thickness using linear models, covarying age, gend...
Background:Alzheimer disease and cerebrovascular dis-ease affect elderly persons through alterations...
Background: It has been proposed that only mild cognitive impairment (MCI) with high Aβ amyloid is i...
Introduction: Hippocampal atrophy is an established Alzheimer’s Disease (AD) biomarker. Volume loss ...
Aims: To assess how hippocampal volume (HV) from volumetric magnetic resonance imaging (vMRI) is rel...
International audienceOBJECTIVE: To investigate whether global and regional beta-amyloid (Abeta) bur...
BACKGROUND: Hippocampal volume (HV) atrophy is a well-known biomarker of memory impairment. However,...
beta-Amyloid deposition is one of the main hallmarks of Alzheimer's disease thought to eventually ca...
The hypothetical model of dynamic biomarkers for Alzheimer’s disease (AD) describes high amyloid dep...
OBJECTIVE:The objective of this study was to test whether effects of β-amyloid (Aβ) pathology on epi...
Background: Alzheimer’s disease pathology (AD) is an important cause of neurodegeneration and brain ...
PurposePosterior cingulate cortex (PCC) hypometabolism as measured by FDG PET is an indicator of Alz...
Although patients with amnestic mild cognitive impairment (aMCI) are at higher risk of developing Al...
BACKGROUND: We investigated the independent effects of Alzheimer's disease (AD) and cerebrovascular ...
Objective: The objective of this study was to test whether effects of b-amyloid (Ab) pathology on ep...
Structural deterioration and volume loss of the hippocampal formation is observed in many diseases a...
Background:Alzheimer disease and cerebrovascular dis-ease affect elderly persons through alterations...
Background: It has been proposed that only mild cognitive impairment (MCI) with high Aβ amyloid is i...
Introduction: Hippocampal atrophy is an established Alzheimer’s Disease (AD) biomarker. Volume loss ...
Aims: To assess how hippocampal volume (HV) from volumetric magnetic resonance imaging (vMRI) is rel...
International audienceOBJECTIVE: To investigate whether global and regional beta-amyloid (Abeta) bur...
BACKGROUND: Hippocampal volume (HV) atrophy is a well-known biomarker of memory impairment. However,...
beta-Amyloid deposition is one of the main hallmarks of Alzheimer's disease thought to eventually ca...
The hypothetical model of dynamic biomarkers for Alzheimer’s disease (AD) describes high amyloid dep...
OBJECTIVE:The objective of this study was to test whether effects of β-amyloid (Aβ) pathology on epi...
Background: Alzheimer’s disease pathology (AD) is an important cause of neurodegeneration and brain ...
PurposePosterior cingulate cortex (PCC) hypometabolism as measured by FDG PET is an indicator of Alz...
Although patients with amnestic mild cognitive impairment (aMCI) are at higher risk of developing Al...
BACKGROUND: We investigated the independent effects of Alzheimer's disease (AD) and cerebrovascular ...
Objective: The objective of this study was to test whether effects of b-amyloid (Ab) pathology on ep...
Structural deterioration and volume loss of the hippocampal formation is observed in many diseases a...
Background:Alzheimer disease and cerebrovascular dis-ease affect elderly persons through alterations...
Background: It has been proposed that only mild cognitive impairment (MCI) with high Aβ amyloid is i...
Introduction: Hippocampal atrophy is an established Alzheimer’s Disease (AD) biomarker. Volume loss ...